NAV
$42.56
AUM
$489.8M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.00
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +6.33% | +1.06% | +2.57% | +19.33% | - | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | SAN.PA | Sanofi SA | 3.13% |
| 2 | SAP | SAP SE ADR | 2.90% |
| 3 | BABA | Alibaba Group Holding Ltd ADR | 2.44% |
| 4 | 4502.T | Takeda Pharmaceutical Co Ltd | 2.23% |
| 5 | WALMEX.MX | Wal - Mart de Mexico SAB de CV | 2.16% |
| 6 | HEN | Henkel AG & Co KGaA | 2.12% |
| 7 | 4503.T | Astellas Pharma Inc | 2.01% |
| 8 | CFR.SW | Compagnie Financiere Richemont SA Class A | 1.94% |
| 9 | HEIO.AS | Heineken Holding NV | 1.93% |
| 10 | DHL.DE | Deutsche Post AG | 1.90% |
The fund is an actively managed exchange-traded fund (“ETF”) that seeks to attain its investment objective by investing primarily in equity securities of foreign companies. The fund typically invests in foreign companies with market capitalizations (market value of publicly traded equity securities) greater than $5 billion at the time of purchase.
Inception Date: 2023-10-03